VGFT-OD-0706

Status: Completed

ClinicalTrials.gov Identifier: NCT00789477

VGFT-OD-0706: Phase 2 study of intravitreal injections of Aflibercept in patients with Diabetic Macular Edema.

Condition: Diabetic Macular Edema

Study Type: Interventional

Duration: 21 months

Eligibility:

  • Ages: 18 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.